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Context  
Nurse Family Partnership (NFP) home visiting from pregnancy to 24 months postpartum, guided by a 
manualised curriculum, has been shown in three RCTs to have multiple beneficial outcomes and to 
be a cost effective way to prevent the risk of child abuse for children of young, psychologically 
vulnerable first-time mothers1. It also strengthens families through increased maternal employment 
and wider spacing of pregnancies and leads to a range of benefits for children through adolescence2.  
The US developed programme was introduced into England in 2007 (renamed Family Nurse 
Partnership) and an RCT launched in 2009. 
 
Methods 
Eligible women (nulliparous, age >20, <25 weeks gestation) living close to established FNP teams 
were screened and referred to the trial, randomised to FNP or comparison (usual care) stratified by 
site, gestation (<16 weeks, 16 weeks +) and smoking status.  Face to face maternal interviews were 
completed at baseline and 24 months with blinded telephone contact in late pregnancy, at 6, 12 and 
18 months postpartum and urine samples taken to confirm smoking status at baseline and in late 
pregnancy. The trial had four primary outcomes: tobacco use in late pregnancy (self-report and 
urine), from health records birthweight, second pregnancy within 24 months postpartum and 
(health records and maternal report) emergency hospital attendances and admissions for the infant. 
Secondary outcomes and contact with health care professionals were collected by maternal report 
at each time point. 
 
Findings 
With 1645 originally randomised, primary outcomes were available for variable numbers (1092 
smoking in pregnancy, 1501 birthweight, 1289 second pregnancy, 1478 emergency episodes). No 
differences were identified in the proportion of mothers smoking in pregnancy (56% both groups), in 
birthweight (3217.4g FNP, 3197.5g control), second pregnancy by 24 months (66% both groups) or 
infant emergency attendance/admission (81% FNP, 77% control). However secondary outcomes 
indicated benefit from FNP. Maternal report of language development at 12, 18 and 24 months and 
cognitive development at 24 months favoured FNP infants and maternal report of social support, 
partner-relationship and self-efficacy showed positive impacts for FNP families. 
 
Commentary  
Robling and colleagues state that smoking cessation and second pregnancies by 24 months are the 
most relevant outcomes and that, with respect to these, the programme cannot be considered cost 
effective.  However these are not the outcomes that have led to the programme being held 
internationally to have top tier evidence and to be cost effective2; that is based on longer-term child 
outcomes such as better school achievement and avoidance of delinquency in adolescence, linked 
with more stimulating, less harsh parenting in childhood.  The authors note that reliance on 
attendance at emergency departments may, in the UK, reflect a style of seeking healthcare that has 
become very common in the UK but is not so typical in the USA.  However the reliance on health 
outcomes from records is the main difficulty with this trial.  If observations had been completed of 
home conditions and parent-infant interactions at 12, 18 and 24 months, and child language had 
been assessed directly at 24 months, positive impacts might have been detected for the most 
important ways that the programme has been seen to influence outcomes.  The paper notes that a 
recent trial in the Netherlands 3 has found positive impacts similar to those found by the 
intervention’s developer David Olds in the USA.  The Dutch trial used more stringent criteria for 
selection leading to a population that more closely resembled that of the participants in the US 
trials.  It is possible that delivery in the UK may need to follow that model.  Suggestions for 
alternative eligibility criteria have been established for the UK4  but noting that more detailed 
information would need to be available in pregnancy records so that vulnerabilities such as mental 
health problems, low educational achievement, or lack of support could be used to identify potential 
clients. 
 
Implications for practice 
 The paper concludes that programme continuation is not justified on the basis of this evidence.  
However it would be unwise for commissioners to make decisions based only on this research study, 
given other evidence suggesting that delivery to the right population leads to many positive parent 
and child outcomes. 
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